ES2156220T3 - Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica. - Google Patents

Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.

Info

Publication number
ES2156220T3
ES2156220T3 ES95941659T ES95941659T ES2156220T3 ES 2156220 T3 ES2156220 T3 ES 2156220T3 ES 95941659 T ES95941659 T ES 95941659T ES 95941659 T ES95941659 T ES 95941659T ES 2156220 T3 ES2156220 T3 ES 2156220T3
Authority
ES
Spain
Prior art keywords
antihistaminal
transdermic
action
preparation containing
loratidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95941659T
Other languages
English (en)
Inventor
Karin Klokkers
Wilfried Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Application granted granted Critical
Publication of ES2156220T3 publication Critical patent/ES2156220T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA PENSADA PARA SU ADMINISTRACION SISTEMICA TRANSDERMICA Y QUE CONTIENE UN METABOLITO DE LORATIDINA COMO SUSTANCIA ACTIVA.
ES95941659T 1994-12-02 1995-12-04 Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica. Expired - Lifetime ES2156220T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4442999A DE4442999A1 (de) 1994-12-02 1994-12-02 Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten

Publications (1)

Publication Number Publication Date
ES2156220T3 true ES2156220T3 (es) 2001-06-16

Family

ID=6534786

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95941659T Expired - Lifetime ES2156220T3 (es) 1994-12-02 1995-12-04 Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.

Country Status (11)

Country Link
US (2) US6165498A (es)
EP (1) EP0794770B1 (es)
AT (1) ATE199496T1 (es)
AU (1) AU4301596A (es)
DE (2) DE4442999A1 (es)
DK (1) DK0794770T3 (es)
ES (1) ES2156220T3 (es)
GR (1) GR3035860T3 (es)
PT (1) PT794770E (es)
WO (1) WO1996016641A1 (es)
ZA (1) ZA9510234B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
AU776837B2 (en) * 1997-02-07 2004-09-23 Sunovion Pharmaceuticals Inc. Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
ATE220546T1 (de) * 1997-04-25 2002-08-15 Schering Plough Kabushiki Kais Augentropfen enthaltend ein loratidinmetabolit
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
WO2001045676A2 (en) 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
DE60141596D1 (de) 2000-10-23 2010-04-29 Euro Celtique Sa Transdermales system zur verabreichung von loratadin und dessen verwendung
DE10360592A1 (de) * 2003-12-19 2005-07-28 Beiersdorf Ag Pflastersystem zur Verabreichung von Antihistaminika
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
KR102081925B1 (ko) 2012-08-29 2020-02-26 엘지전자 주식회사 디스플레이 디바이스 및 스피치 검색 방법
DE202018106738U1 (de) * 2018-11-27 2018-12-06 Amoena Medizin-Orthopädie-Technik GmbH Kompressions-Büstenhalter zur postoperativen Versorgung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten

Also Published As

Publication number Publication date
DE4442999A1 (de) 1996-06-05
ZA9510234B (en) 1996-09-02
DE59509084D1 (de) 2001-04-12
US6165498A (en) 2000-12-26
WO1996016641A1 (de) 1996-06-06
US6395297B1 (en) 2002-05-28
GR3035860T3 (en) 2001-08-31
EP0794770A1 (de) 1997-09-17
ATE199496T1 (de) 2001-03-15
EP0794770B1 (de) 2001-03-07
PT794770E (pt) 2001-08-30
AU4301596A (en) 1996-06-19
DK0794770T3 (da) 2001-04-17

Similar Documents

Publication Publication Date Title
ES2156220T3 (es) Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
ES2159591T3 (es) Composicion de liberacion controlada.
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
PY950041A (es) Compuesto de 1- fenil 3-dimetilamino- propano a procedimientos para su preparacion y a la aplicacion de estas sustancias en farmacologia
ES2103563T3 (es) Esteres nitricos con una actividad farmacologica y procedimiento para su preparacion.
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
AR019690A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ES531978A0 (es) Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
AR240225A1 (es) Composicion insecticida que comprende mas de un compuesto activo.
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
ES2174293T3 (es) Microesferas farmaceuticas de acido valproico para la administracion oral.
HN1998000144A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa.
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
MX9306419A (es) Bifenilos trisustituidos, procedimiento para su obtencion y medicamentos que los contienen.
ES2180737T3 (es) Conjugado para la dosificacion individual de medicamentos, su procedimiento de preparacion y su uso en los mismos.
MX9302487A (es) Piridonas sustituidas por bifenilmetilo, procedimiento para su obtencion y medicamentos que las contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 794770

Country of ref document: ES